UK markets open in 1 hour 51 minutes

PharmaCyte Biotech, Inc. (PMCB)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
2.1600-0.0200 (-0.92%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/04/2023
30/04/2022
30/04/2021
Total revenue
0
0
0
0
Operating expenses
Research development
749.373
468.536
690.937
916.249
Selling general and administrative
5,614
4,752
2,156
1,278
Total operating expenses
6,363
6,455
4,392
3,623
Operating income or loss
-6,363
-6,455
-4,392
-3,623
Interest expense
0
0
0.509
3.046
Total other income/expenses net
-7.167
202.002
-4.283
74.791
Income before tax
-5,660
-4,316
-4,239
-3,551
Income from continuing operations
-5,660
-4,316
-4,239
-3,551
Net income
-5,660
-4,316
-4,239
-3,551
Net income available to common shareholders
-5,660
-4,316
-4,239
-3,551
Basic EPS
-0.23
-0.22
-0.27
-2.45
Diluted EPS
-0.23
-0.22
-0.27
-2.45
Basic average shares
21,156
19,489
15,522
1,448
Diluted average shares
21,156
19,489
15,522
1,448